You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

Frequent Liver Function Tests Can Detect Transient ALT Increases in Chronic Hepatitis B Patients
3-20-2009

Adefovir (Hepsera) Prevents Post-transplant HBV Recurrence as well as HBIG
1-27-2009

HBV Reactivation Leads to a High Risk of Fulminant Liver Failure and Death
9-05-2008

Guidelines:
Treatment for Hepatitis B: When to Start, What to Use, and When to Stop
March 2009
European Association for the Study of the Liver (EASL) Publishes First Guidelines for Management of Chronic Hepatitis B
February 2009
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update
March 2008

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 Google Custom Search
FDA-approved Therapies for Chronic HBV Infection
Baraclude  (entecavir)
Epivir-HBV
  (lamivudine; 3TC)
Hepsera
  (adefovir dipivoxil)
Intron A  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
Viread  (tenofovir)
Tyzeka   (telbivudine)

Experimental Treatments

HBV Articles by Topic

Cirrhosis
Fibrosis
Hepatocellular Carcinoma
Liver Transplantation

Steatosis
Children / Infants / Women
Hepatitis B Clinical Trials
Experimental Treatments
FAQs About Hepatitis
Genotypes
Guidelines
Tests for HBV
Vaccines for HBV